Delivering relief and patient satisfaction, risk-free.
Freespira offers a transformative solution to address one of the largest problems we face in healthcare: anxiety disorders. As the only medical device with FDA indications for panic disorder and PTSD, Freespira offers patients access to a validated treatment they can use at home. And now, Freespira is also available for teens as part of our new FDA indication for adolescents ages 13-17 experiencing stress and anxiety.
What Makes Zero Risk… Zero Risk?
Freespira’s Zero Risk program focuses on minimizing risk in four key areas:
- Performance Guarantee: Freespira offers health plans a financial performance guarantee of 1:1 ROI in Year 1.
- Outcomes-Based Pricing: Freespira’s outcomes-based pricing provides assurance that health plans will only pay full price for members who achieve clinical outcomes benchmarks.
- Engagement Program: The program targets only those plan members who are candidates for the Freespira treatment, and absorbs the workload associated with member outreach and engagement.
- Reduced Burden: The Freespira partnership model reduces the burden on health plan staff by lowering internal implementation lift and account management oversight.
Case Study: Point32Health and Freespira
Freespira’s solution delivered impressive outcomes while improving treatment access for Point32Health's members.
What our health plan partners are saying...
"Freespira has health economic evidence demonstrating the cost-effectiveness and potential cost savings associated with its treatment compared to the standard of care. By highlighting reductions in healthcare utilization such as emergency department visits and medication use, Freespira aligned its value proposition with health plan and payor priorities – continuous quality improvement and healthcare cost containment. Freespira has the ability to improve member access to health care regardless of geographic or economic barriers."
– Karen Fischbach, fmr. Sr. Manager, Strategic Business Lead, Point32Health
"The breakthrough drug-free treatment approach has reduced the impact of symptoms associated with panic disorder and PTSD, resulting in reduced use of medications and other healthcare costs for symptom management."
- Demetrios C. Marousis, MA, MBA, LPC, Director, Behavioral Health, Highmark, Inc.
"I think what differentiates Freespira is that they have the ability to engage members, they have the ability to talk with them one on one, to do an assessment to understand the applicability of Freespira to their condition, and then effectuate the ability to deliver that via device in a timely manner.
– Jason Parent, fmr. Director of Clinical Innovation, Point32Health
Ready to be part of the future of mental health?
Join the growing number of health plans embracing innovation without compromise. Freespira’s Zero Risk Program is available now.